← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$12K

Shares

1,530

Price

$8

Filed

Feb 18

Insider

Name

Sabatini Brent

Title

SVP, Chief Accounting Officer

CIK

0002037272

Roles

Officer

Transaction Details

Transaction Date

2026-02-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,872

Footnotes

Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person. | Includes 2,290 and 485 shares of common stock acquired by the Reporting Person on May 30, 2025 and November 28, 2025, respectively, pursuant to an employee stock purchase program.

Filing Info

Accession No.

0001628280-26-008984

Form Type

4

Issuer CIK

0001706431

Sabatini Brent's History

Date Ticker Type Value
2026-03-23 VIR $70K
2026-02-24 VIR $14K
2026-02-23 VIR $14K
2026-02-22 VIR A $0
2026-02-22 VIR A $0
2026-02-13 VIR $12K

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $783K 2026-04-01
De Backer Marianne
Chief Executive Officer
$283K 2026-02-24
De Backer Marianne
President and CEO
$664K 2026-04-06
Eisner Mark
EVP and Chief Medical Officer
$50K 2026-02-25
O'Byrne Jason
EVP & Chief Financial Officer
$31K 2026-02-24
de Verneuil Vanina
EVP, General Counsel, Corp Sec
$197K 2026-02-25
Sabatini Brent
SVP, Chief Accounting Officer
$98K 2026-03-23